Osteoarthritis of the knee
Conditions
Interventions
None listed
Sponsors
Centrexion Therapeutics Corp.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Outcome results
None listed
A Pilot, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of a Single Intra-articular Injection of CNTX-0066 in Participants with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Feb 25, 2026